Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Yilmaz, M. Birhan (7202595585)"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association
    (2018)
    Doehner, Wolfram (6701581524)
    ;
    Ural, Dilek (6603790014)
    ;
    Haeusler, Karl Georg (23569221900)
    ;
    Čelutkienė, Jelena (6507133552)
    ;
    Bestetti, Reinaldo (7005929953)
    ;
    Cavusoglu, Yuksel (7003632889)
    ;
    Peña-Duque, Marco A. (56013566400)
    ;
    Glavas, Duska (15762332500)
    ;
    Iacoviello, Massimo (6603668699)
    ;
    Laufs, Ulrich (26643295500)
    ;
    Alvear, Ricardo Marmol (57200864506)
    ;
    Mbakwem, Amam (6506969430)
    ;
    Piepoli, Massimo F. (7005292730)
    ;
    Rosen, Stuart D. (7401609522)
    ;
    Tsivgoulis, Georgios (6701335522)
    ;
    Vitale, Cristiana (7005091702)
    ;
    Yilmaz, M. Birhan (7202595585)
    ;
    Anker, Stefan D. (56223993400)
    ;
    Filippatos, Gerasimos (7003787662)
    ;
    Seferovic, Petar (6603594879)
    ;
    Coats, Andrew J.S. (35395386900)
    ;
    Ruschitzka, Frank (7003359126)
    Heart failure (HF) is a complex clinical syndrome with multiple interactions between the failing myocardium and cerebral (dys-)functions. Bi-directional feedback interactions between the heart and the brain are inherent in the pathophysiology of HF: (i) the impaired cardiac function affects cerebral structure and functional capacity, and (ii) neuronal signals impact on the cardiovascular continuum. These interactions contribute to the symptomatic presentation of HF patients and affect many co-morbidities of HF. Moreover, neuro-cardiac feedback signals significantly promote aggravation and further progression of HF and are causal in the poor prognosis of HF. The diversity and complexity of heart and brain interactions make it difficult to develop a comprehensive overview. In this paper a systematic approach is proposed to develop a comprehensive atlas of related conditions, signals and disease mechanisms of the interactions between the heart and the brain in HF. The proposed taxonomy is based on pathophysiological principles. Impaired perfusion of the brain may represent one major category, with acute (cardio-embolic) or chronic (haemodynamic failure) low perfusion being sub-categories with mostly different consequences (i.e. ischaemic stroke or cognitive impairment, respectively). Further categories include impairment of higher cortical function (mood, cognition), of brain stem function (sympathetic over-activation, neuro-cardiac reflexes). Treatment-related interactions could be categorized as medical, interventional and device-related interactions. Also interactions due to specific diseases are categorized. A methodical approach to categorize the interdependency of heart and brain may help to integrate individual research areas into an overall picture. © 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Recommendations on pre-hospital & early hospital management of acute heart failure: A consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine
    (2015)
    Mebazaa, Alexandre (57210091243)
    ;
    Yilmaz, M. Birhan (7202595585)
    ;
    Levy, Phillip (7202556643)
    ;
    Ponikowski, Piotr (7005331011)
    ;
    Peacock, W. Frank (35446270800)
    ;
    Laribi, Said (36017071600)
    ;
    Ristic, Arsen D. (7003835406)
    ;
    Lambrinou, Ekaterini (9039387200)
    ;
    Masip, Josep (57221962429)
    ;
    Riley, Jillian P. (7402484485)
    ;
    McDonagh, Theresa (7003332406)
    ;
    Mueller, Christian (57638261900)
    ;
    Defilippi, Christopher (57207615660)
    ;
    Harjola, Veli-Pekka (6602728533)
    ;
    Thiele, Holger (57223640812)
    ;
    Piepoli, Massimo F. (7005292730)
    ;
    Metra, Marco (7006770735)
    ;
    Maggioni, Aldo (57203255222)
    ;
    McMurray, John (58023550400)
    ;
    Dickstein, Kenneth (7005037423)
    ;
    Damman, Kevin (8677384800)
    ;
    Seferovic, Petar M. (6603594879)
    ;
    Ruschitzka, Frank (7003359126)
    ;
    Leite-Moreira, Adelino F. (35448017900)
    ;
    Bellou, Abdelouahab (7003571332)
    ;
    Anker, Stefan D. (56223993400)
    ;
    Filippatos, Gerasimos (7003787662)
    Acute heart failure is a fatal syndrome. Emergency physicians, cardiologists, intensivists, nurses and other health care providers have to cooperate to provide optimal benefit. However, many treatment decisions are opinion-based and few are evidenced-based. This consensus paper provides guidance to practicing physicians and nurses to manage acute heart failure in the pre-hospital and hospital setting. Criteria of hospitalization and of discharge are described. Gaps in knowledge and perspectives in the management of acute heart failure are also detailed. This consensus paper on acute heart failure might help enable contiguous practice. © 2015 The Authors. European Journal of Heart Failure © 2015 European Society of Cardiology.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Recommendations on pre-hospital and early hospital management of acute heart failure: A consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine - Short version
    (2015)
    Mebazaa, Alexandre (57210091243)
    ;
    Yilmaz, M. Birhan (7202595585)
    ;
    Levy, Phillip (7202556643)
    ;
    Ponikowski, Piotr (7005331011)
    ;
    Peacock, W. Frank (35446270800)
    ;
    Laribi, Said (36017071600)
    ;
    Ristic, Arsen D. (7003835406)
    ;
    Lambrinou, Ekaterini (9039387200)
    ;
    Masip, Josep (57221962429)
    ;
    Riley, Jillian P. (7402484485)
    ;
    McDonagh, Theresa (7003332406)
    ;
    Mueller, Christian (57638261900)
    ;
    DeFilippi, Christopher (57207615660)
    ;
    Harjola, Veli-Pekka (6602728533)
    ;
    Thiele, Holger (57223640812)
    ;
    Piepoli, Massimo F. (7005292730)
    ;
    Metra, Marco (7006770735)
    ;
    Maggioni, Aldo (57203255222)
    ;
    McMurray, John J.V. (58023550400)
    ;
    Dickstein, Kenneth (7005037423)
    ;
    Damman, Kevin (8677384800)
    ;
    Seferovic, Petar M. (6603594879)
    ;
    Ruschitzka, Frank (7003359126)
    ;
    Leite-Moreira, Adelino F. (35448017900)
    ;
    Bellou, Abdelouahab (7003571332)
    ;
    Anker, Stefan D. (56223993400)
    ;
    Filippatos, Gerasimos (7003787662)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Treatments targeting inotropy
    (2019)
    Maack, Christoph (6701763468)
    ;
    Eschenhagen, Thomas (7004716470)
    ;
    Hamdani, Nazha (23094208600)
    ;
    Heinze, Frank R. (57212263844)
    ;
    Lyon, Alexander R. (57203046227)
    ;
    Manstein, Dietmar J. (7006283059)
    ;
    Metzger, Joseph (7202074710)
    ;
    Papp, Zoltan (29867593800)
    ;
    Tocchetti, Carlo G. (6507913481)
    ;
    Yilmaz, M. Birhan (7202595585)
    ;
    Anker, Stefan D. (56223993400)
    ;
    Balligand, Jean-Luc (7003921084)
    ;
    Bauersachs, Johann (7004626054)
    ;
    Brutsaert, Dirk (7006117073)
    ;
    Carrier, Lucie (55199727100)
    ;
    Chlopicki, Stefan (7003634171)
    ;
    Cleland, John G. (7202164137)
    ;
    De Boer, Rudolf A. (8572907800)
    ;
    Dietl, Alexander (55324535700)
    ;
    Fischmeister, Rodolphe (7006457996)
    ;
    Harjola, Veli-Pekka (6602728533)
    ;
    Heymans, Stephane (6603326423)
    ;
    Hilfiker-Kleiner, Denise (6602676885)
    ;
    Holzmeister, Johannes (6603169763)
    ;
    De Keulenaer, Gilles (6603078918)
    ;
    Limongelli, Giuseppe (6603359014)
    ;
    Linke, Wolfgang A. (7004812764)
    ;
    Lund, Lars H. (7102206508)
    ;
    Masip, Josep (57221962429)
    ;
    Metra, Marco (7006770735)
    ;
    Mueller, Christian (57638261900)
    ;
    Pieske, Burkert (35499467500)
    ;
    Ponikowski, Piotr (7005331011)
    ;
    Risti, Arsen (18936987100)
    ;
    Ruschitzka, Frank (7003359126)
    ;
    Seferovi, Petar M. (57212274303)
    ;
    Skouri, Hadi (21934953600)
    ;
    Zimmermann, Wolfram H. (7203058782)
    ;
    Mebazaa, Alexandre (57210091243)
    Acute heart failure (HF) and in particular, cardiogenic shock are associated with high morbidity and mortality. A therapeutic dilemma is that the use of positive inotropic agents, such as catecholamines or phosphodiesteraseinhibitors, is associated with increased mortality. Newer drugs, such as levosimendan or omecamtiv mecarbil, target sarcomeres to improve systolic function putatively without elevating intracellular Ca2þ. Although meta-analyses of smaller trials suggested that levosimendan is associated with a better outcome than dobutamine, larger comparative trials failed to confirm this observation. For omecamtiv mecarbil, Phase II clinical trials suggest a favourable haemodynamic profile in patients with acute and chronic HF, and a Phase III morbidity/mortality trial in patients with chronic HF has recently begun. Here, we review the pathophysiological basis of systolic dysfunction in patients with HF and the mechanisms through which different inotropic agents improve cardiac function. Since adenosine triphosphate and reactive oxygen species production in mitochondria are intimately linked to the processes of excitation-contraction coupling, we also discuss the impact of inotropic agents on mitochondrial bioenergetics and redox regulation. Therefore, this position paper should help identify novel targets for treatments that could not only safely improve systolic and diastolic function acutely, but potentially also myocardial structure and function over a longer-term. © 2018 The Author(s).

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback